SEC Form 4 · accession 0001562180-18-003542
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hippel
Officer — Chief Financial Officer
Period of report
Aug 7, 2018
Accepted (ET)
Aug 9, 2018 · 6:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 7, 2018 | M | 2,398 | $0.00 | A | 5,477 | D | |
| Common Stock | Aug 7, 2018 | F | 1,094 | $180.14 | D | 4,382 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Aug 7, 2018 | M | 2,398 | D | — | — | Common Stock | 2,398 | 602 | D |
| Restricted Stock UnitsF1,F2 | — | Aug 7, 2018 | D | 602 | D | — | — | Common Stock | 602 | 0 | D |
| Stock Options (Right to buy)F3 | $108.49 | Aug 7, 2018 | D | 3,762 | D | — | Aug 7, 2022 | Common Stock | 3,762 | 14,988 | D |
| Restricted Stock UnitsF1,F4 | — | Aug 8, 2018 | A | 3,383 | A | — | — | Common Stock | 3,383 | 3,383 | D |
| Stock Options (Right to buy)F5 | $177.32 | Aug 8, 2018 | A | 24,089 | A | — | Aug 8, 2025 | Common Stock | 24,089 | 24,089 | D |
| Stock Options (Right to buy)F4 | $177.32 | Aug 8, 2018 | A | 18,066 | A | — | Aug 8, 2025 | Common Stock | 18,066 | 18,066 | D |
| Restricted Stock UnitsF1,F6 | — | holding | — | — | — | — | — | Common Stock | 4,438 | 4,438 | D |
| Restricted Stock UnitsF7,F8 | — | holding | — | — | — | — | — | Common Stock | 4,925 | 4,925 | D |
| Stock Option (Right to Buy)F9 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 30,400 | 30,400 | D |
| Stock Option (Right to Buy)F10 | $94.35 | holding | — | — | — | — | Aug 12, 2021 | Common Stock | 35,000 | 35,000 | D |
| Stock Option (Right to Buy)F11 | $86.25 | holding | — | — | — | — | Apr 1, 2021 | Common Stock | 10,000 | 10,000 | D |
| Stock Options (Right to buy)F6 | $125.05 | holding | — | — | — | — | Aug 9, 2024 | Common Stock | 24,460 | 24,460 | D |
| Stock Options (Right to buy)F12 | $125.05 | holding | — | — | — | — | Aug 9, 2024 | Common Stock | 32,613 | 32,613 | D |
| Stock Options (Right to buy)F13 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 25,000 | 25,000 | D |
| Stock Options (Right to buy)F14 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 40,533 | 40,533 | D |
| Stock Options (Right to buy)F11 | $86.25 | holding | — | — | — | — | Apr 1, 2021 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F108,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
- F11Fully exercisable
- F12Vests 8,153 shares each on 8/19/2018, 8/9/2019, 8/9/2020 and 8,154 on 8/9/2021
- F136,250 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
- F14Vests 10,134 shares on 8/18/17, and 10,133 shares on each of 8/18/18, 8/18/19 and 8/18/20.
- F2On 8/7/2018, the Board of Directors authorized discretionary vesting for 2,398 performance RSUs. The remainder of the performance RSUs were forfeited.
- F3On 8/7/2018, the Board of Directors authorized discretionary vesting for 14,988 performance options. The remainder of the performance options were forfeited.
- F4Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F5Vests 6,023 shares on 8/8/2019, 6,022 shares on each 8/8/2020, 8/8/2021, 8/8/2022
- F6Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F7Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
- F8Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)
- F9Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Remarks
Amount of Securities Beneficially Owned Following Reported Transaction was overstated by 1 share on previous filed Form 4